President Emeritus – Vincent Chan, Ph.D., MIT

Vincent is a Research Scientist in the d’Arbeloff Lab in Mechanical Engineering at the Massachusetts Institute of Technology (MIT). He was educated in Biomedical Engineering at UIUC (PhD ’12), Purdue (MS ’08), and Johns Hopkins (BS ’06). Vincent is also the current President of the MIT Postdoctoral Association. He served as Senior Manager at Illinois Business Consulting, the largest student-run management consulting organization in the United States. When not at work or in the lab, Vincent is an avid runner, gym rat, and sports fan.


President – Johnny Hu, Harvard

Johnny is a PhD candidate at Harvard working on protein engineering. He received his AB in Chemical and Physical Biology from Harvard and MPhil in Neuroscience from the University of Cambridge. He is interested in seeing how academia and industry can work together to develop new innovations.


Vice President – Lyndon Charles, Ph.D., MIT

Lyndon received his Ph.D. in Biomedical Science from the University of Connecticut, and is currently a postdoctoral researcher at MIT in the Edelman lab. He is a part of a research team focusing on the development of novel orthopedic materials for regeneration and repair of bone and cartilage tissue. His main interest is in enhancing connections between Boston’s academic and industry biotech players to increase biomedical innovations and ease of translation.


Director of Strategic Advancement – Batula Zaidi Lesher, Ph.D., Independent Consultant

Batula received her doctorate in cancer genomics at the Cleveland Clinic as a Howard Hughes scholar. As a Postdoctoral Scholar at the Whitehead Institute at MIT, she lead a team that translated patient genetic data to identify better drug targets for Parkinson’s patients. She is currently an independent consultant for academic labs and pharmaceutical companies.


Event Coordinator – Karen Duffy, Unum Therapeutics

Karen Duffy earned a Bachelors of Science in Biological Engineering and a Masters of Engineering in Biomedical Engineering both from Cornell University. She is currently at AstraZeneca, where she works in drug discovery research in the Innovative Medicines unit. As a member of the Biotech Connection, she is excited about connecting people and ideas that can drive scientific innovation and deliver real impact to patients.


Editor-in-Chief – Chris Van, Ph.D., University of Massachusetts

Christopher Van is a chromatin biologist working with Dr. Craig Peterson.  After earning degrees in Chemistry and Biochemistry and Molecular Biology from Penn State, he joined Stanford’s PhD program in Chemical and Systems Biology to study the molecular mechanisms responsible for maintaining genomic integrity.  He is now a postdoctoral researcher at the UMass Medical School with Dr. Peterson, a world-renowned leader in the field of epigenetics.  His current projects and collaborations focus on understanding the role of chromatin modifying enzymes in DNA replication and repair.


Social Media Manager – Carla D'Avanzo, Ph.D., MGH/Harvard Medical School

Carla received her PhD in Neuroscience from University Federico II in Naples, Italy. She then joined Kim’s lab at MGH, Harvard Medical School as Postdoc Associate where she has been working on characterizing a novel 3D human stem cells culture system that shows key events in the pathogenic cascade of Alzheimer’s disease. She is really passionate about social media communication and event planning, she is co-chair of the MGH Postdocs Association and board member of the Harvard Italian Society where she helps in planning career development and networking events.


Business Development Manager – Alex Badamchi-Zadeh, Ph.D., Harvard Medical School

Alex is a Postdoctoral Fellow at Harvard Medical School, with a research focus on immunotherapy and vaccination for chronic diseases and cancers. He received his MA(Oxon) in Biological Sciences from the University of Oxford (Christ Church), and his MRes and PhD in Clinical Medicine (Immunology) from Imperial College London. Alex is interested in connecting disruptive/innovative/translational research in immunology from academia to industry.